Celebrate Thanksgiving with 30% Off! 🦃 Use Code THANKFUL2024. Hurry, Ends Nov 30!
0
0
0
Weeks
0
0
0
0
Days
0
0
Hrs
0
0
Min
0
0
Sec

RECORDED WEBCAST

Exploring the Business Valuation Landscape: Key Considerations

2023-07-18T22:06:09-04:00

Over the past years, businesses across all industries have experienced various changes and challenges in business valuation due to the constantly changing market. Several factors, including geopolitical issues, difficulties in workforce management, and inflation, continue to add up to these difficulties. With the uncertainties ahead, valuing business remains a tough call.

Chapter 11 Corporate Bankruptcy Reorganizations: Leases and Executory Contracts

2023-06-29T23:58:43-04:00

A Chapter 11 bankruptcy involves numerous complex issues.  One of the most complex elements of a chapter 11 bankruptcy can be the treatment of executory contracts and unexpired leases.  The application of bankruptcy laws to the terms of a contract or lease can significantly alter the rights and obligations of all parties to the agreement.  A thorough understanding of how bankruptcy laws intersect with contracts and leases is critical for companies considering a chapter 11 restructuring, parties to an agreement with a financially distressed counterparty, and purchasers of bankrupt businesses, among many others. 

The Intersection of Cannabis and Corporate Law: Navigating Complex Federal and State Laws

2023-07-12T02:09:49-04:00

The unceasingly evolving field of cannabis continues to bring complex regulatory challenges among businesses and legal practitioners. Although still illegal under federal law, several states and territories in the US have already legalized the use of cannabis for both medical and recreational purposes. In April 2022, the U.S. House of Representatives passed the Marijuana Opportunity Reinvestment and Expungement (MORE) Act. If passed by the Senate, the MORE Act would abolish criminal penalties for federal cannabis offenses, decriminalize cannabis at the federal level, and expunge past federal cannabis convictions.

Mental Health and Wellness for Lawyers: Diversifying and Scaling Up Care Options

2023-03-27T23:53:12-04:00

The high level of stress and heavy workloads in the legal industry are drastically impacting the mental health of legal professionals. While the alarming rise in the number of affected lawyers has sparked preventive measures to nurture their mental health, other issues like stigma and fear of the negative implications on their careers are what hold lawyers back from speaking up. Thus, fostering awareness of the mental health challenges facing the profession and highlighting solutions are critical in upholding a meaningful workplace culture and work-life balance among lawyers.

Significant FDA Enforcement Developments: Challenges and Opportunities

2023-05-24T22:15:41-04:00

FDA’s enforcement landscape continues to evolve as the agency implements its new legislative authorities, advances its regulation of cutting-edge issues, addresses significant supply chain concerns, and deals with the fallout from the COVID-19 public health emergency. Despite the evolving landscape, enforcement related to manufacturing and data integrity-related deficiencies and unapproved new products remain at the core of the agency’s enforcement priorities.

Advancing Trial Skills: Critical Steps to an Effective Cross-Examination

2023-05-31T22:14:57-04:00

One integral aspect to increase the chances of winning a trial is the use of cross-examination. While this approach takes extensive planning and preparation, a properly executed and effective cross-examination can be an opportunity to test the reliability and credibility of witness evidence, expose weaknesses, and likely produce a favorable testimony. Thus, practitioners must develop sound strategies and calculated trial preparations to avoid disjointed cross-examination.

Major Reforms in R&D Tax Credits 2023: Exploring Opportunities for Your Firm

2023-01-27T04:25:58-05:00

The Tax Cuts and Jobs Act (TCJA) has been beneficial for companies engaged in research and development (R&D). It kept the R&D tax credit permanent and eliminated other tax credits and incentives in exchange for lower tax rates. However, beginning after December 31, 2021, the taxpayer option to deduct current R&D expenditures was abolished. It now requires the charging of expenditures to a capital account and amortizing them in a specified number of years.

Go to Top